Bempedoic acid and cardiovascular outcomes in statin intolerant patients

Treatment of elevated LDL cholesterol levels is a central component of modern therapy to reduce the risk of serious cardiovascular events in patients with primary or secondary prevention. However, 7% to 29% of patients report muscular side effects that prevent them from taking statins or increasing the dose to meet guidelines. A recent study published in NEJM suggests alternative strategies.